For Immediate Release

Chicago, IL – October 20, 2009 – Zacks Equity Research highlights Pozen, Inc. (POZN) as the Bull of the Day and Rite Aid Corporation (RAD) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Hasbro Inc.(HAS), Mattel Inc. (MAT) and JAKKS Pacific Inc.(JAKK).

Full analysis of all these stocks is available at http://at.zacks.com/?id=2676

Here is a synopsis of all five stocks:

Bull of the Day:

Pozen, Inc. (POZN) is one of our top-picks for small-cap biotech. We see the fundamentals as strong and the valuation as low.

We are pleased to see the NDA for Vimovo (PN-400) filed and now accepted by the U.S. FDA. FDA acceptance earned Pozen a $10 million milestone from AstraZeneca in August. We expect sales of Treximet to ramp in the coming quarters now that the groundwork has been

...

Management at Rite Aid Corporation (RAD) was executing a turnaround strategy centered on increasing the profitability of the existing store base. However, the acquisition of Brooks Eckerd prior to a convincing turnaround in profitability has increased the debt burden and interest expense.

Moreover, Wal-Mart's foray into the retail generic drug market has pressured the company's pharmacy margin. Given the weakness of front-end sales and management's continual lowering of EPS guidance (for larger net losses), the stock's rating remains Underperform.Zacks Investment Research

For Immediate Release

Chicago, IL – October 14, 2009 – Zacks Equity Research highlights VimpelCom (VIP) as the Bull of the Day and Rite Aid Corporation (RAD) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Johnson & Johnson (JNJ), Elan Pharmaceuticals (ELN) and Gilead Sciences, Inc. (GILD).

Full analysis of all these stocks is available at http://at.zacks.com/?id=2676

Here is a synopsis of all five stocks:

Bull of the Day:

We reaffirm our Outperform recommendation for VimpelCom (VIP), Russia's second largest cellular carrier with over 25% market share. Reported earnings in the last quarter outpaced the Zacks Consensus Estimate, driven by foreign exchange gains.

We continue to be intrigued by VimpelCom's successful sales growth trend and its ability to retain subscribers on a recurring basis, even as overall economic factors remain weak. The company is also progressing

...

Management at Rite Aid Corporation (RAD) was executing a turnaround strategy centered on increasing the profitability of the existing store base.

However, the acquisition of Brooks Eckerd prior to a convincing turnaround in profitability has increased the debt burden and interest expense.

Moreover, Wal-Mart's foray into the retail generic drug market has pressured the company's pharmacy margin. Given the weakness of front-end sales and management's continual lowering of EPS guidance (for larger net losses), the stock's rating remains Underperform.Zacks Investment Research

The Board of Directors of Walgreens (WAG) approved a 22.2% quarterly dividend increase from 11.25 cents to 13.75 cents, payable on September 12, 2009, to shareholders on record as of August 21, 2009. The annualized dividend is raised to $0.55 from $0.45 per share.

The dividend increase is testimony of the company’s confidence in its key growth strategies and its ability to generate strong cash flow going forward. WAG is the largest national retail pharmacy chain in terms of revenue and profitability and has paid a dividend in 307 straight quarters (more than 76 years) and raised its dividend for 34 consecutive years. The company has increased its dividend by an average compound annual rate of more than 21% over the last five years. The company operated 6,902 drug stores in 50 states in the U.S. and Puerto Rico as of June 30, 2009.

The company reported strong third-quarter sales increasing

...

The outlook for the drug store industry is negative. Although the demographics of an aging U.S. population are favorable for the prescription drug industry, the outlook for pharmacies remains clouded due to several influences on the industry.

Competition will remain stiff in the pharmacy segment as other retail businesses continue to add pharmacy departments and as other low-cost pharmacy options come on-line. Discount retailers, in particular, have made substantial inroads in gaining market share during the last year. The trend toward generic drugs, while providing better margins for retail pharmacists, is expected to slow over the next year. In addition, various drug re-importation schemes have been proposed by large employers and state and local governments in an effort to manage escalating healthcare costs.

Clouding the outlook further is the legislation that provides drug benefits under Medicare. Real GDP declined 6.3% in the fourth quarter of 2008, and the

...

For Immediate Release

Chicago, IL - June 22, 2009 - Zacks Equity Research highlights NCR Corporation (NCR) as the Bull of the Day and Rite Aid Corporation (RAD) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Avon Products (AVP), Kimberly-Clark (KMB) and Pepsi Bottling Group (PBG).

Full analysis of all these stocks is available at http://at.zacks.com/?id=2676.

Here is a synopsis of all five stocks:

Bull of the Day:

Given its robust business model, aggressive cost-cutting measures and new business initiatives, we expect NCR Corporation (NCR) to resume growth across segments later this year. This should be sustainable for the foreseeable future as its customers seek to cut costs through increased automation.

However, NCR experienced a significant drop off in business activity in the retail segment in

...

For Immediate Release

Chicago, IL - June 22, 2009 - Zacks Equity Research highlights NCR Corporation (NCR) as the Bull of the Day and Rite Aid Corporation (RAD) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Avon Products (AVP), Kimberly-Clark (KMB) and Pepsi Bottling Group (PBG).

Full analysis of all these stocks is available at http://at.zacks.com/?id=2676.

Here is a synopsis of all five stocks:

Bull of the Day:

Given its robust business model, aggressive cost-cutting measures and new business initiatives, we expect NCR Corporation (NCR) to resume growth across segments later this year. This should be sustainable for the foreseeable future as its customers seek to cut costs through increased automation.

However, NCR experienced a significant drop off in business activity in the retail segment in

...

Management at Rite Aid Corporation (RAD) was executing a turnaround strategy centered on increasing the profitability of the existing store base.

However, the acquisition of Brooks Eckerd prior to a convincing turnaround in profitability has increased the debt burden and interest expense. Moreover, Wal-Mart's foray into the retail generic drug market has pressured the company's pharmacy margin.

Given the weakness of front-end sales, especially in the past fiscal year, and management's continual lowering of EPS guidance (for larger net losses), the stock's rating is a Sell.Zacks Investment Research